News

KIKA Clinical Solutions offers Veracity EDC platform. The company claimed that its Veracity is a web-based clinical trial software platform that delivers clinical asset management for any size

Luye Pharma is expected to contribute its licensed rights to Crofelemer in China including Macao and Hong Kong for the indications of chronic diarrhea in people living with

As per the terms of the acquisition, an upfront payment corresponding to an enterprise value for MIP Technologies of 16MSEK will be made. In addition further payments based

In addition, the two entities have also signed an exclusive distribution agreement for the commercialisation of Daxas in the UK. As per the terms of the agreement, Nycomed

Charles River Laboratories International is a global provider of research models and associated services and of preclinical drug development services, while WuXi PharmaTech (Cayman) is a drug research

Transposagen Biopharmaceuticals said academic, pharmaceutical, and biotech scientists use these animals for drug discovery and development research and are expected to be sold under its new TGEM Rat

UCB said that FDA’s response is to an NDA Supplement, which was submitted by the company in June 2009, with a proposal for new refrigerated storage conditions to

The modified Regenesis Phase IIb trial is a placebo controlled, double blinded, 3:1 randomised clinical study, enrolled 96 patients with acute ischemic stroke between August 2009 and January

The joint venture represents a new opportunity for both companies to expand their business in the pharmaceutical market in China. As per the terms of the agreement, Macfarlan